iPharma | Semaglutide 5mg (Izempic, Not Mixed) | Compound Peptide Vial
Advanced GLP-1 Receptor Research Compound
IPHARMA Izempic 5mg is an investigational GLP-1 receptor research compound studied in laboratory environments for its role in metabolic signalling pathways, glucose regulation mechanisms, and appetite-related endocrine responses.
Semaglutide-related compounds are widely referenced in scientific research exploring incretin hormone activity, insulin secretion dynamics, and energy balance regulation within controlled experimental and biochemical models.
Developed as a 5mg compound peptide vial (Not Mixed), this formulation is supplied in an unmixed format intended for laboratory preparation and controlled research applications where GLP-1 receptor activity and metabolic pathway investigation are of scientific interest.
IPHARMA Izempic 5mg Compound Peptide Vial (Not Mixed)
• GLP-1 receptor research compound studied in metabolic signalling models
• Investigated in glucose regulation and insulin response research
• Of interest in appetite signalling and energy balance studies
• Explored in incretin hormone pathway research environments
• 5mg unmixed vial format designed for laboratory preparation use
• Supplied in “Not Mixed” form for controlled research handling
• High-purity investigational formulation from IPHARMA
• Strictly intended for laboratory research use only
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPHRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
